1,860
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Association between short inter-pregnancy interval and placenta previa and placenta accreta spectrum with respect to maternal age at first cesarean delivery

, , , , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2192853 | Received 13 Jul 2022, Accepted 14 Mar 2023, Published online: 26 Mar 2023

References

  • Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012;33(4):244–251.
  • Solheim KN, Esakoff TF, Little SE, et al. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341–1346.
  • Bowman ZS, Eller AG, Bardsley TR, et al. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31(9):799–804.
  • Vintzileos AM, Ananth CV, Smulian JC. Using ultrasound in the clinical management of placental implantation abnormalities. Am J Obstet Gynecol. 2015;213(4 Suppl):S70–S7.
  • Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126(3):654–668.
  • Vahanian SA, Lavery JA, Ananth CV, et al. Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol. 2015;213(4 Suppl):S78–S90.
  • Downes KL, Hinkle SN, Sjaarda LA, et al. Previous prelabor or intrapartum cesarean delivery and risk of placenta previa. Am J Obstet Gynecol. 2015;212(5):669.e1-6–669.e6.
  • Bose DA, Assel BG, Hill JB, et al. Maintenance tocolytics for preterm symptomatic placenta previa: a review. Am J Perinatol. 2011;28(1):45–50.
  • Hasegawa J, Nakamura M, Hamada S, et al. Prediction of hemorrhage in placenta previa. Taiwan J Obstet Gynecol. 2012;51(1):3–6.
  • Taki M, Sato Y, Kakui K, et al. Management of fetal death with placenta previa. J Matern Fetal Neonatal Med. 2012;25(2):196–199.
  • Frederiksen MC, Glassenberg R, Stika CS. Placenta previa: a 22-year analysis. Am J Obstet Gynecol. 1999;180(6 Pt 1):1432–1437.
  • O'Brien JM. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2007;109(1):203–204; (author reply 204).
  • Dahlke JD, Mendez-Figueroa H, Maggio L, et al. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. Am J Obstet Gynecol. 2015;213(1):76. e1–76.e10.
  • Gibbins KJ, Einerson BD, Varner MW, et al. Placenta previa and maternal hemorrhagic morbidity. J Matern Fetal Neonatal Med. 2018;31(4):494–499.
  • Royal College of Obstetricians and Gynaecologists. Blood transfusions in obstetrics. Green-top guideline no. 47. London: RCOG; 2015.
  • Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529–1536.
  • Carcopino X, d‘Ercole C, Bretelle F. Optimal management strategies for placenta accreta. BJOG. 2009;116(11)1538; (author reply :1538; author reply 1538–1538; author reply 1539).
  • Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115(1):65–69.
  • Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226–1232.
  • Bailit JL, Grobman WA, Rice MM, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;125(3):683–689.
  • Lumbiganon P, Laopaiboon M, Gülmezoglu AM, et al. World health organization global survey on maternal and perinatal health research group. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007–08. Lancet. 2010;375(9713):490–499.
  • Yan J, Wang L, Yang Y, et al. The trend of caesarean birth rate changes in China after 'universal two-child policy’ era: a population-based study in 2013-2018. BMC Med. 2020;18(1):249.
  • 21.Liang J, Mu Y, Li X, et al. Relaxation of the one child policy and trends in caesarean section rates and birth outcomes in China between 2012 and 2016: observational study of nearly seven million health facility births. BMJ. 2018;360:k817.
  • Zhang H-X, Zhao Y-Y, Wang Y-Q. Analysis of the characteristics of pregnancy and delivery before and after implementation of the two- child policy. Chin Med J. 2018;131(1):37–42.
  • Zeng C, Yang M, Ding Y, et al. Placenta accreta spectrum disorder trends in the context of the universal two-child policy in China and the risk of hysterectomy. Int J Gynaecol Obstet. 2018;140(3):312–318.
  • Schummers L, Hutcheon JA, Hernandez-Diaz S, et al. Association of short interpregnancy interval with pregnancy outcomes according to maternal age. JAMA Intern Med. 2018;178(12):1661–1670.
  • Zhang L, Shen S, He J, et al. Effect of interpregnancy interval on adverse perinatal outcomes in Southern China: a retrospective cohort study, 2000-2015. Paediatr Perinat Epidemiol. 2018;32(2):131–140.
  • McKinney D, House M, Chen A, et al. The influence of interpregnancy interval on infant mortality. Am J Obstet Gynecol. 2017;216(3):316.e1–316.e9.
  • Marinovich ML, Regan AK, Gissler M, et al. Associations between interpregnancy interval and preterm birth by previous preterm birth status in four high-income countries: a cohort study. BJOG. 2021;128(7):1134–1143.
  • Tessema GA, Pereira G. Challenging the assumption that interpregnancy interval causes stillbirth in low-income and middle-income countries. Lancet Glob Health. 2020;8(1):e16–e17.
  • Kollmann M, Gaulhofer J, Lang U, et al. Placenta praevia: incidence, risk factors and outcome. J Matern Fetal Neonatal Med. 2016;29(9):1395–1398.
  • Saleh Gargari S, Seify Z, Haghighi L, et al. Risk factors and consequent outcomes of placenta previa: report from a referral center. Acta Med Iran. 2016;54(11):713–717.
  • Zhang X, Xu H, Hu R, et al. Changing trends of adverse pregnancy outcomes with maternal age in primipara with singleton birth: a join point analysis of a multicenter historical cohort study in China in 2011–2012. Acta Obstet Gynecol Scand. 2019;98(8):997–1003.
  • Bi S, Zhang L, Chen J, et al. Maternal age at first cesarean delivery related to adverse pregnancy outcomes in a second cesarean delivery: a multicenter, historical, cross-sectional cohort study. BMC Pregnancy Childbirth. 2021;21(1):126.
  • ACOG Committee Opinion No 736: optimizing postpartum care. Obstet Gynecol. 2018;131(5):e140–e150.
  • Office of Disease Prevention and Health Promotion. Healthy People.gov. US Healthy people 2020 family planning objective 5. Healthy People 2020 Web site. https://www.healthypeople.gov/2020/topics-objectives/topic/family-planning/objectives. Updated September 7, 2018. Accessed March 3,2018.
  • Garg B, Darney B, Pilliod RA, et al. Long and short interpregnancy intervals increase severe maternal morbidity. Am J Obstet Gynecol. 2021;225(3):331.e1–331.e8.
  • Liu C, Snowden JM, Lyell DJ, et al. Interpregnancy interval and subsequent severe maternal morbidity: a 16-year population-based study from California. Am J Epidemiol. 2021;190(6):1034–1046.
  • Martimucci K, Bilinski R, Perez AM, et al. Interpregnancy interval and abnormally invasive placentation. Acta Obstet Gynecol Scand. 2019;98(2):183–187.
  • WHO guidelines on preventing early pregnancy and poor reproductive health outcomes among adolescents in developing countries. Geneva: World Health Organization; 2011.
  • United Nations Population Fund. Girlhood, not motherhood: preventing adolescent pregnancy. New York: United Nations Population Fund; 2015.
  • United Nations Population Fund. State of world population 2016. 10: how our future de - pends on a girl at this decisive age. New York: United Nations Population Fund; 2016.
  • The National Campaign to Prevent Teen and Unplanned Pregnancy. Briefly: unplanned pregnancy among unmarried young women. 2012.
  • Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84(5):478–485.
  • Kornides ML, Kitsantas P, Lindley LL, et al. Factors associated with young adults’ pregnancy likelihood. J Midwifery Womens Health. 2015;60(2):158–168.
  • Norton M, Chandra-Mouli V, Lane C. Interventions for preventing unintended, rapid repeat pregnancy among adolescents: a review of the evidence and lessons from High-Quality evaluations. Glob Health Sci Pract. 2017;5(4):547–570.
  • Wong SPW, Twynstra J, Gilliland JA, et al. Risk factors and birth outcomes associated with teenage pregnancy: a Canadian sample. J Pediatr Adolesc Gynecol. 2020; Apr33(2):153–159.
  • Cook JL, Green CR, de la Ronde S, et al. Epidemiology and effects of substance use in pregnancy. J Obstet Gynaecol Can. 2017;39(10):906–915.
  • Irvine B, Dzakpasu S, León JA. Perinatal health indicators 2013: a surveillance report by the public health agency of Canada’s perinatal surveillance system. Health Promot Chronic Dis Prev Can. 2015;35(1):23–24.
  • East KA, Reid JL, Rynard VL, et al. Trends and patterns of tobacco and nicotine product use among youth in Canada, England, and the United States from 2017 to 2019. J Adolesc Health. 2021;69(3):447–456.
  • Jauniaux E, Chantraine F, Silver RM, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140(3):265–273.
  • Jung EJ, Cho HJ, Byun JM, et al. Placental pathologic changes and perinatal outcomes in placenta previa. Placenta. 2018;63:15–20.
  • Chen X, Man GCW, Liu Y, et al. Physiological and pathological angiogenesis in endometrium at the time of embryo implantation. Am J Reprod Immunol. 2017;78(2):e12693.